6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

Size: px

Start display at page:

Download "6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:"

Alberta Lamb
5 years ago
Views:

1 6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations:

LIST OF FACULTY Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy Dr. Sonsoles Alonso Dr.

David Cibula General University Hospital and Charles University in Prague, The Czech Republic The University of Texas MD Anderson Cancer Center,

Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France Dr. Francisco Javier García Prado Dr.

Halaska Charles University in Prague, The Czech Republic Dr. Amir Anthony Jazaeri The University of Texas MD Anderson Cancer Center, Houston, USA Dr.

Meyer The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Bradley J. Monk Creighton University School of Medicine at St.

Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain Dr. Patricia Pradera Dr.

2 LIST OF FACULTY Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy Dr. Sonsoles Alonso Dr. Alessandro Buda San Gerardo Hospital, Monza, Italy Dr. Natalia Carballo Dr. Antonio Casado Hospital Clínico Univ. San Carlos, Madrid, Spain Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Santiago Domingo Hospital Univ. i Politècnic La Fe, Valencia, Spain Dr. María Fernández-Chereguini Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France Dr. Francisco Javier García Prado Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France Dr. Michael J. Halaska Charles University in Prague, The Czech Republic Dr. Amir Anthony Jazaeri The University of Texas MD Anderson Cancer Center, Houston, USA Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany Dr. Sergio Martínez Hospital Univ. Germans Trias i Pujol, Barcelona, Spain Dr. Larissa A. Meyer The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph s Hospital and Medical Center, Phoenix, USA Dr. Jordi Ponce Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain Dr. Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain Dr. Patricia Pradera Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu, Paris, France Dr. Jose Alejandro Rauh-Hain The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA Dr. Anil Sood The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Gemma Toledo Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA

3 6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Wednesday, May 9 th, :00-11:15 WELCOME AND INTRODUCTION Dr. Pedro Luis Cobiella Hospiten Group President Dr. Shannon N. Westin SURGERY IN OVARIAN CANCER 11:15-11:35 Surgical trials in gynecologic oncology. A critical appraisal Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic 11:35-11:55 Laparoscopy in interval debulking surgery in ovarian cancer Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy 11:55-12:15 Ovarian cancer. Moon shot program Dr. Anil Sood 12:15-12:35 Early recovery after surgery program (ERAS) Dr. Larissa A. Meyer 12:35-13:00 Questions & Discussion

4 KEYNOTE LECTURE Moderator: 13:00-13:40 Target microenvironmental opportunities in ovarian cancer 13:40-15:10 Lunch FIRST LINE TREATMENT OF OVARIAN CANCER. TARGET DISCOVERY AND NOVEL THERAPEUTICS Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy 15:10-15:30 Predicting resectability for primary debulking surgery in MD Anderson Cancer Center Madrid 15:30-15:50 Principles and concepts of cytoreductive surgery. Importance of surgical training Dr. Sergio Martínez Hospital Univ. Germans Trias i Pujol, Barcelona, Spain 15:50-16:10 Optimal setting for antiangiogenic agents in first line. Evidence or preference Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph s Hospital and Medical Center, Phoenix, USA 16:10-16:30 Neoadjuvant setting 16:30-16:50 HIPEC. Do we have any evidence so far? Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France 16:50-17:10 Questions & Discussion 17:10-17:40 Coffee break

5 CONTROVERSIES IN FRONTLINE OVARIAN CANCER Dr. Santiago Domingo Hospital Univ. i Politècnic La Fe, Valencia, Spain Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France 17:40-18:00 Guided lymphadenectomy in ovarian cancer. Any sense in LION s era? Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany 18:00-18:30 Debate: IP chemotherapy in ovarian cancer 18:00-18:15 Pro 18:15-18:30 Against Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph s Hospital and Medical Center, Phoenix, USA 18:30-18:45 Questions & Discussion

6 CHALLENGING CASES IN GYNECOLOGICAL CANCER Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu, Paris, France Dr. Jordi Ponce Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain 08:30-08:50 Management of advanced stage and recurrent low grade serous ovarian cancer Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA 08:50-09:10 Finding the patient for pelvic exenteration Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France 09:10-09:30 Contemporary management of uterine leiomyosarcoma Dr. Jose Alejandro Rauh-Hain 09:30-10:00 Questions & Discussion 10:00-10:30 Coffee break Thursday, May 10 th, 2018 CERVICAL CANCER Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France 10:30-11:00 Contemporary management of advanced and recurrent cervical cancer Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph s Hospital and Medical Center, Phoenix, USA 11:00-11:30 Rationale for only sentinel node in cervical cancer. Must we subselect patients? Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic

7 11:30-12:00 Stage Ib2 cervical cancer. Other options than chemoradiation 11:30-11:45 Radiotherapist Dr. Natalia Carballo 11:45-12:00 Gynecologic oncologist Dr. Michael J. Halaska Charles University in Prague, The Czech Republic 12:00-12:30 Questions & Discussion KEYNOTE LECTURE Moderator: 12:30-13:15 Inmunotherapy updates: can we use inmune system to treat gynecological cancer? Dr. Amir Anthony Jazaeri 13:15-14:45 Lunch ENDOMETRIAL CANCER Dr. Sergio Martínez Hospital Univ. Germans Trias i Pujol, Barcelona, Spain 14:45-15:05 Update on conservative treatment. Ongoing trials Dr. Shannon N. Westin 15:05-15:45 The genomic data to clinical application in endometrial cancer patients. Clinical cases Dr. Sonsoles Alonso

8 15:45-16:25 Stage IIIC2 endometrial cancer 15:45-16:05 Radiotherapy Dr. Natalia Carballo 16:05-16:25 Chemotherapy Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA 16:25-16:45 Sentinel node mapping algorithm versus selective lymphadenectomy in early stage endometrial cancer Dr. Alessandro Buda San Gerardo Hospital, Monza, Italy 16:45-17:05 ICG guided peritoneal mesometrial resection with targeted compartmental lymphadenectomy in endometrial cancer Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany 17:05-17:35 Questions & Discussion 17:35-18:05 Coffee break PERSONALIZING DECISIONS IN RECURRENT GYNECOLOGIC CANCER TREATMENT Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA Dr. Amir Anthony Jazaeri 18:05-18:25 Prolonging PFS with non-platinum in ovarian cancer Dr. Antonio Casado Hospital Clínico Univ. San Carlos, Madrid, Spain 18:25-18:45 PARPi s: Where are we and where are we going? Dr. Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain 18:45-19:05 Treatments in novel targets in the recurrent setting Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu, Paris, France 19:05-19:30 Questions & Discussion

9 Friday, May 11 th, 2018 MISCELLANEOUS Dr. Sonsoles Alonso Dr. María Fernández-Chereguini 08:30-08:50 Universal genetic testing Dr. Shannon N. Westin 08:50-09:10 Social and psycological support Dr. Patricia Pradera 09:10-09:30 Quality of life and patient reported outcomes. How do they inform clinical trials? Dr. Larissa A. Meyer 09:30-09:45 Questions & Discussion 09:45-10:45 TUMOR BOARD 10:45-11:15 Coffee break Panel: Dr. David Cibula Dr. Gemma Toledo Dr. Eric Pujade-Lauraine Dr. Shannon N. Westin Dr. Natalia Carballo Dr. Francisco Javier García Prado

11:15-14:00 VIDEO WORKSHOP 11:15-12:45 EXPERTS 11:15-11:45 Open surgery Dr.

11:45-12:15 Laparoscopic surgery 12:15-12:45 Robotic surgery Dr.

Cancer Center Madrid video contest in gyne-onco surgery for young surgeons

10 11:15-14:00 VIDEO WORKSHOP 11:15-12:45 EXPERTS 11:15-11:45 Open surgery Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France 11:45-12:15 Laparoscopic surgery 12:15-12:45 Robotic surgery Dr. Jose Alejandro Rauh-Hain 12:45-14:00 YOUNG SURGEONS First MD Anderson Cancer Center Madrid video contest in gyne-onco surgery for young surgeons RULES & GUIDELINES AVAILABLE ON THE WEBSITE 14:00 CLOSING REMARKS Dr. Shannon N. Westin

SPONSORSHIP: Gold Silver Bronze Collaborator UNDER THE

Pastrana Paseo de la Habana, 208 28016 Madrid (Spain)

be provided ACCREDITATION: Applications for CME credits

Council for Continuing Medical Education and to the

ACOE accreditation is endorsed by EACCME, the European

an institution of the European Union of Medical

The UEMS-EACCME and the AMA (American Medical

With the collaboration of the Educational Committee of

MEETING SECRETARIAT: C/ Monasterios de Suso y Yuso 34,

12 SPONSORSHIP: Gold Silver Bronze Collaborator UNDER THE AUSPICES OF: ORGANIZED BY: VENUE: Auditorio Duques de Pastrana Paseo de la Habana, Madrid (Spain) LANGUAGE: Simultaneous translation English/Spanish will be provided ACCREDITATION: Applications for CME credits have been forwarded to the Spanish Accreditation Council for Continuing Medical Education and to the Accreditation Council for Oncology in Europe (ACOE). ACOE accreditation is endorsed by EACCME, the European Accreditation Council for Continuous Medical Education, an institution of the European Union of Medical Specialists (UEMS). The UEMS-EACCME and the AMA (American Medical Association) recognize each other s CME credits. With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid. MEETING SECRETARIAT: C/ Monasterios de Suso y Yuso 34, Madrid Phone: (+34) gynecologiconcology2018@doctaforum.com Registration:

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards